MA grocery card use was associated with modest increases in wellness, primary care, and specialist visits among dual-eligible ...
Victor Appay, PhD, explains how long-term ART slows immune aging, boosting HIV viral suppression and paving the way for ...
Cost concerns among GLP-1 users extend beyond individual financial strain to perceptions of broader health care system sustainability. More than 70% of respondents supported minimum coverage ...
Doxy-PEP reshapes STI prevention, while congenital syphilis surges; experts urge scaling HIV and STI care infrastructure to ...
The largest nursing strike came to an end on February 21, 2026, after 41 days. The 3 health systems being protested, Mount Sinai, NewYork-Presbyterian, and Montefiore, addressed nurses’ demands and ...
Tina Bhatnagar, DO, speaks to the importance of diversity in clinical trials and the need to remove barriers, enroll underrepresented backgrounds, and reflect real-world health conditions. The push ...
Acalabrutinib (Calquence; AstraZeneca) demonstrated a more modest ORR of 40% in a smaller 25-patient cohort, with median progression-free survival (PFS) of 3.2 months. While less robust than ...
Mark Meiselbach, PhD, at Johns Hopkins Bloomberg School of Public Health, explains Medicare Advantage market corrections, Star Rating System pressures, and rural plan exits.
GLP-1 receptor agonists improve glycemic control and weight while reducing cardiovascular events, with tolerability limited by gastrointestinal adverse effects requiring gradual dose escalation.
Research Director at INSERM and co-head of the "Vulnerability and Ageing of the Immune System" team at the ImmunoConcEpT unit (UMR 5164) of the University of Bordeaux ...
Executive actions in 2025 produced a 90-day freeze and stop orders; waivers incompletely restored services, with notable gaps in PrEP access for nonpregnant, nonbreastfeeding individuals. New research ...
The increase in CRC-related mortality in younger adults is driven by screening delays and advanced-stage diagnoses, according to Jordan Karlitz, MD.